Literature DB >> 7259789

Hypoxia and drug metabolism.

D P Jones.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7259789     DOI: 10.1016/0006-2952(81)90436-6

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  16 in total

Review 1.  Intravital fluorescence videomicroscopy to study tumor angiogenesis and microcirculation.

Authors:  P Vajkoczy; A Ullrich; M D Menger
Journal:  Neoplasia       Date:  2000 Jan-Apr       Impact factor: 5.715

2.  Hepatocellular necrosis, fibrosis and microsomal activity determine the hepatic pharmacokinetics of basic drugs in right-heart-failure-induced liver damage.

Authors:  Peng Li; Thomas A Robertson; Qian Zhang; Linda M Fletcher; Darrell H G Crawford; Michael Weiss; Michael S Roberts
Journal:  Pharm Res       Date:  2012-06       Impact factor: 4.200

Review 3.  The hepatic sinusoid in aging and cirrhosis: effects on hepatic substrate disposition and drug clearance.

Authors:  David G Le Couteur; Robin Fraser; Sarah Hilmer; Laurent P Rivory; Allan J McLean
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

4.  Hypoxia-induced down-regulation of CYP1A1/1A2 and up-regulation of CYP3A6 involves serum mediators.

Authors:  Caroline Fradette; Anne-Marie Bleau; Vincent Pichette; Nathalie Chauret; Patrick Du Souich
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

Review 5.  Vascular microenvironment in gliomas.

Authors:  P Vajkoczy; M D Menger
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

Review 6.  Arteriolar oxygen reactivity: where is the sensor and what is the mechanism of action?

Authors:  William F Jackson
Journal:  J Physiol       Date:  2016-07-21       Impact factor: 5.182

Review 7.  The metabolic function of the lung.

Authors:  W J Wijnands
Journal:  Pharm Weekbl Sci       Date:  1987-04-24

8.  Toxicity of t-butylhydroperoxide in hepatocyte monolayers exposed to hypoxia and reoxygenation.

Authors:  A K Costa; D F Heffel; T M Schieble; J R Trudell
Journal:  In Vitro Cell Dev Biol       Date:  1987-07

Review 9.  The effect of respiratory disorders on clinical pharmacokinetic variables.

Authors:  A M Taburet; C Tollier; C Richard
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

Review 10.  Fetal alcohol syndrome: the vulnerability of the developing brain and possible mechanisms of damage.

Authors:  J R West; W J Chen; N J Pantazis
Journal:  Metab Brain Dis       Date:  1994-12       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.